Home » Newsletters » BioWorld Asia

BioWorld Asia

July 5, 2000

View Archived Issues

Modex Raises US$103M In IPO In Switzerland To Fund Programs

Pharmagene Plans To Go Public In London, Says Time Is Right

Research Shows Strategies For Malaria Could Be Off Target

Mologen Raises EUR12.45M For Phase III Cancer Trials

European Stem Cell Debate Provokes Deeper Questions

Metris Raises #11M Privately For Work On Women's Health

Transghne, IntroGene Collaborate To Produce Adenoviral Vectors

Molecular Engine Formed To Exploit Novel Cancer Approach

IDM Issued U.S. Patent Covering Cell Preparation

Other News To Note

Oxford BioMedica Demonstrates Utility Of LentiVector Technology

Memorec Seeks Up To US$15M For Integrated Genomics Work

Australian Consortium Awarded $16M By NIH For AIDS Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...